Literature DB >> 7068840

Clinical significance of viridans streptococci isolated from blood cultures.

F J Swenson, S J Rubin.   

Abstract

The clinical significance of viridans streptococci isolated from the blood cultures of 86 patients was determined. Isolates that were significant or suggestive of infection represented only 21% of the cases. Among 54 isolates for which the species was known, Streptococcus sanguis II was the most common. However, a significant association between species and clinical significance was not found.

Entities:  

Mesh:

Year:  1982        PMID: 7068840      PMCID: PMC272173          DOI: 10.1128/jcm.15.4.725-727.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  5 in total

1.  Transitory bacteremia.

Authors:  H M COBE
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1954-06

2.  Streptococci isolated from post-extraction bacteraemias.

Authors:  J M Symington
Journal:  Br J Oral Surg       Date:  1975-07

3.  Clinical significance of Lancefield groups L-T streptococci isolated from blood and cerebrospinal fluid.

Authors:  C V Broome; R C Moellering; B K Watson
Journal:  J Infect Dis       Date:  1976-04       Impact factor: 5.226

4.  Clinical significance of enterococci in blood cultures from adult patients.

Authors:  L D Wells; A von Graevenitz
Journal:  Infection       Date:  1980       Impact factor: 3.553

5.  Physiological differentiation of viridans streptococci.

Authors:  R R Facklam
Journal:  J Clin Microbiol       Date:  1977-02       Impact factor: 5.948

  5 in total
  8 in total

1.  E test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci.

Authors:  S J Rosser; M J Alfa; S Hoban; J Kennedy; G K Harding
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

Review 2.  Epidemiology of antimicrobial resistance in bloodstream infections.

Authors:  Murat Akova
Journal:  Virulence       Date:  2016-04-02       Impact factor: 5.882

3.  Prospective study of Streptococcus milleri bacteremia.

Authors:  E Casariego; A Rodriguez; J C Corredoira; P Alonso; A Coira; M Bal; M J López; J Varela
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-03       Impact factor: 3.267

4.  Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study.

Authors:  J C Corredoira; M P Alonso; J F García; E Casariego; A Coira; A Rodriguez; J Pita; C Louzao; B Pombo; M J López; J Varela
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-04       Impact factor: 3.267

5.  Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases.

Authors:  W Kern; E Kurrle; T Schmeiser
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

6.  Differential medium for mixed cultures of alpha-hemolytic streptococci from blood.

Authors:  L Graham; F A Meier; H P Dalton
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

7.  Streptococcus mitis strains causing severe clinical disease in cancer patients.

Authors:  Samuel A Shelburne; Pranoti Sahasrabhojane; Miguel Saldana; Hui Yao; Xiaoping Su; Nicola Horstmann; Erika Thompson; Anthony R Flores
Journal:  Emerg Infect Dis       Date:  2014-05       Impact factor: 6.883

8.  Clinical Outcomes of Ceftriaxone vs Penicillin G for Complicated Viridans Group Streptococci Bacteremia.

Authors:  Stephanie Wo; Yanina Dubrovskaya; Justin Siegfried; John Papadopoulos; Shin-Pung Jen
Journal:  Open Forum Infect Dis       Date:  2020-11-07       Impact factor: 3.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.